About Genomed
Genomed is a publicly listed company based in Szczecin (Poland) founded in 2008 by Anna Boguszewska-Chachulska and Andrzej Palucha. Composite yachts and industrial components are manufactured via laminating techniques. It operates on a HealthTech and Professional Services model. Its chief executive, as recorded, is Anna Boguszewska-Chachulska. Genomed offers products and services including Genetic Testing, Whole Genome Sequencing (WGS), and Personalized Medicine. Its focus areas include Biotechnology and Genetic Testing. Its legal entity is Genomed S.A. Its competitors include Geneme, Nex Bio and Crisprmice; 1 of its 3 listed competitors has raised funding.
Company details
Genomed S.A. is involved in providing advanced genetic testing and molecular diagnostics services in Poland and Europe. The company specializes in DNA sequencing using Next Generation Sequencing (NGS) technology, offering whole exome and genome sequencing for over 6,500 genes related to genetic disorders. Services are extended to personalized medicine, aiming to integrate genomic prevention into medical practice. Additionally, DNA sequencing and synthesis services are provided for research and biotechnological markets. The focus is maintained on innovation and technological advancement in the healthcare sector.
- Headquarters Szczecin, Poland
- Founders Anna Boguszewska-Chachulska, Andrzej Palucha
- Stage Public
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website genomed.pl
- Social LinkedIn X Facebook
- Legal Name Genomed S.A.
- Annual Revenue$8.11 M (USD)26.58as on Dec 31, 2025
- Net Profit$946.46 K (USD)207.59as on Dec 31, 2025
- EBITDA$1.4 M (USD)140.41as on Dec 31, 2025
Products & Services of Genomed
Genomed offers a comprehensive portfolio of products and services, including Genetic Testing, Whole Genome Sequencing (WGS), and Personalized Medicine.
Genetic testing services are provided for health diagnostics.
Whole genome sequencing is offered for genetic analysis.
Personalized medicine solutions are developed for individual care.
People of Genomed
2 people are tracked at Genomed (2 in leadership).
| Name | Role | Group |
|---|---|---|
Anna Boguszewska-Chachulska | Co-Founder & CEO | Leadership |
Andrzej Palucha | Co-Founder | Leadership |
Complete people profiles for Genomed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Genomed
Genomed is a publicly listed company on the NEWCONNECT with ticker symbol GEN in Poland, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 May 2011
- Listed onNEWCONNECT: GEN
- Listed entityGenomed S.A.
- Exchange sectorHealth services
- ISINPLGNOMD00024
- Share price37.20 PLN · 2026-10-02
- Market capitalisation49,152,398.00 PLN
- Price to earnings14.1
- EPS (diluted, trailing year)2.64 PLN
- Dividend yield4.03%
Financials of Genomed
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 29.1M PLN | 3.4M PLN | 5.0M PLN |
| 2024 | 23.0M PLN | 1.1M PLN | 2.1M PLN |
| 2023 | 22.5M PLN | 926,250 PLN | 2.1M PLN |
| 2022 | 20.5M PLN | 337,960 PLN | 1.1M PLN |
| 2021 | 19.9M PLN | 1.2M PLN | 1.8M PLN |
Detailed financial statements for Genomed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Genomed
Genomed has 3 listed competitors in our database, 1 of them funded. They include Geneme, Nex Bio and Crisprmice.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| geneme.eu | 2018 | Gdansk, Poland | $6.33M | Genetic tests for disease diagnostics are developed using PCR technology. | ||
| nexbio.pl | 2015 | Lubin, Poland | Next-generation DNA analysis services, including genotyping and sequencing, are offered. | |||
| crisprmice.eu | 2014 | Warsaw, Poland | Creates genetically modified mouse models using CRISPR/Cas9 technology. |
Detailed competitors of Genomed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genomed
The website of Genomed (genomed.pl) receives about 8.8K visits a month.
- Monthly visits8.8K
▲ 12.4% vs previous month
Websites whose visitors overlap most with Genomed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
przegladokulistyczny.pl | przegladokulistyczny.pl | 100% | #4,590,525 | β | |
| genesis.pl | 100% | 8.8K | #2,319,778 | View details | |
| zdrowegeny.pl | 90% | 97.2K | #414,540 | View details | |
genetico.pl | genetico.pl | 89% | #2,807,968 | β | |
genetyka.com | genetyka.com | 84% | #7,966,869 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 26 similar websites and full traffic analytics for Genomed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genomed
Complete news archive for Genomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genomed
Genomed was founded in 2008.
Genomed is headquartered in Szczecin, Poland. It is registered at Szczecin, West Pomeranian Voivodeship, Poland.
Anna Boguszewska-Chachulska is the CEO of Genomed, as recorded in our data. They have also founded this company.
Annual revenue of Genomed is $8.11M as on Dec 31, 2025.
Genomed S.A. is involved in providing advanced genetic testing and molecular diagnostics services in Poland and Europe. The company specializes in DNA sequencing using Next Generation Sequencing (NGS) technology, offering whole exome and genome sequencing for over 6,500 genes related to genetic disorders. Services are extended to personalized medicine, aiming to integrate genomic prevention into medical practice. Additionally, DNA sequencing and synthesis services are provided for research and biotechnological markets. The focus is maintained on innovation and technological advancement in the healthcare sector.
Genomed's top competitors include Geneme, Nex Bio and Crisprmice.
Genomed offers Genetic Testing, Whole Genome Sequencing (WGS), and Personalized Medicine.
Yes, Genomed is publicly traded on NEWCONNECT under the ticker symbol GEN.
Genomed operates through Genomed S.A..